Rapid cardiovascular disease test SC-1477-20
creatine kinaseserumplasma

rapid cardiovascular disease test
rapid cardiovascular disease test
Add to favorites
Compare this product
 

Characteristics

Applications
for cardiovascular diseases
Tested parameter
creatine kinase
Sample type
serum, plasma, whole blood
Analysis mode
fluorescence immunoassay

Description

SCREEN IFA TEST CK-MB Fluorescence Immunoassay Ck-Mb REF: SC-1477-20 Test for the diagnosis of MB Creatine Kinase (CK-MB) by measuring on whole blood, serum or plasma with the use of the Immunofluorescence Analyzer. For professional in vitro diagnostic use only. The CK-MB Cassette Test (Whole Blood / Serum / Plasma) is an immunochromatographic test for the quantitative detection of human CK-MB on whole blood, serum or plasma as an aid in the diagnosis of myocardial infarction (MI). Creatine Kinase MB (CK-MB) is an enzyme found in heart muscle with a molecular weight of 87.0 kDa1. Creatine Kinase is a dimeric molecule formed by two subunits called “M” and “B” which combine to form three different isoenzymes, CK-MM, CK-BB and CK-MB. CK-MB is the creatine kinase isoenzyme most involved in the metabolism of heart muscle tissue2. The release of CK-MB into the blood following MI can be detected within 3-8 hours of the onset of symptoms. It peaks after 9-30 hours and returns to baseline after 48-72 hours3. CK-MB is a major cardiac marker and is widely recognized as a typical marker for the diagnosis of MI. The CK-MB Cassette Test (Whole Blood / Serum / Plasma) is a simple test that uses a combination of antibody coated particles and capture reagents to quantitatively detect CK-MB in whole blood, serum or plasma. The CK-MB Cassette Test (Whole Blood / Serum / Plasma) is based on immunofluorescence.

Catalogs

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.